$441M
$114,000
0.0% of portfolio
25,311
Q1 2025
Added 3,161.73%
$262M
$329,000
0.0% of portfolio
43,452
Q1 2025
Reduced 7.47%
$49.4M
$15,000
0.0% of portfolio
9,924
Q3 2024
Reduced 2.47%
$21.7M
$61,000
0.0% of portfolio
56,287
Q1 2025
Reduced 33.23%
$1.38B
$1.1 Million
0.0% of portfolio
365,035
Q1 2025
Reduced 7.93%
$1.58B
$3.18 Million
0.0% of portfolio
107,090
Q1 2025
Added 419.22%
$112M
$851,000
0.0% of portfolio
126,579
Q1 2025
Added 21.34%
$3.55B
$2.59 Million
0.0% of portfolio
151,541
Q1 2025
Reduced 51.17%
$162M
$0
0.0% of portfolio
16
Q4 2024
New
$49.7B
$2.91 Million
0.0% of portfolio
40,269
Q1 2025
Added 335,475.0%
$3B
$2.83 Million
0.0% of portfolio
31,250
Q1 2025
Reduced 31.85%
-
$442,000
0.0% of portfolio
-
Q1 2025
Reduced 69.71%
-
$15,000
0.0% of portfolio
-
Q2 2024
Added 1,125,000.0%
$4.1B
$7.21 Million
0.0% of portfolio
339,569
Q1 2025
Reduced 36.86%
$2.95B
$4.23 Million
0.0% of portfolio
67,513
Q1 2025
Reduced 29.15%
$637M
$2.33 Million
0.0% of portfolio
75,478
Q1 2025
Reduced 10.07%
$0
$119,000
0.0% of portfolio
7,539
Q1 2025
Added 5.53%
$328M
$512,000
0.0% of portfolio
251,475
Q1 2025
Reduced 12.9%
-
$12.8 Million
0.0% of portfolio
-
Q1 2025
Added 73.81%
$213M
$824,000
0.0% of portfolio
239,834
Q1 2025
Reduced 11.93%
-
$410,000
0.0% of portfolio
-
Q1 2025
New
$5.77B
$2.83 Million
0.0% of portfolio
162,162
Q1 2025
Added 125.35%
$227M
$410,000
0.0% of portfolio
104,898
Q1 2025
Reduced 5.1%
$125M
$157,000
0.0% of portfolio
28,977
Q1 2025
Reduced 7.95%
$1.65B
$2.04 Million
0.0% of portfolio
51,503
Q1 2025
Reduced 25.65%
$873M
$2.97 Million
0.0% of portfolio
45,638
Q1 2025
Added 15.2%
-
$2,000
0.0% of portfolio
-
Q1 2025
Reduced 99.76%
Inhibikase Therapeutics Inc
-
$184,000
0.0% of portfolio
-
Q4 2024
New
-
$185,000
0.0% of portfolio
-
Q1 2025
Reduced 29.5%
$1.21B
$2.05 Million
0.0% of portfolio
115,387
Q1 2025
Reduced 38.67%
$138M
$154,000
0.0% of portfolio
19,842
Q1 2025
Reduced 38.03%
$174M
$1,000
0.0% of portfolio
307
Q3 2024
Reduced 25.49%
$1.19B
$1.26 Million
0.0% of portfolio
35,146
Q1 2025
Reduced 17.98%
$2.17B
$3.46 Million
0.0% of portfolio
36,487
Q1 2025
Reduced 20.09%
$538M
$58,000
0.0% of portfolio
19,593
Q1 2025
Reduced 32.67%
-
$0
0.0% of portfolio
-
Q3 2024
New
$1.59B
$2.05 Million
0.0% of portfolio
37,860
Q1 2025
Reduced 25.4%
$193M
$1,000
0.0% of portfolio
183
Q1 2025
Reduced 95.53%
-
$146,000
0.0% of portfolio
-
Q1 2025
Added 2,678.87%
-
$148,000
0.0% of portfolio
-
Q1 2025
Reduced 2.3%
-
$52,000
0.0% of portfolio
-
Q4 2024
New
$0
$135,000
0.0% of portfolio
3,890
Q1 2025
Reduced 22.12%
-
$171,000
0.0% of portfolio
-
Q1 2025
Added 17.54%
$0
$4,000
0.0% of portfolio
115
Q1 2025
New
-
$149,000
0.0% of portfolio
-
Q1 2025
Added 45.4%
$0
$12,000
0.0% of portfolio
330
Q1 2025
Added 10.0%
-
$144,000
0.0% of portfolio
-
Q1 2025
Added 19.12%
-
$46,000
0.0% of portfolio
-
Q1 2025
New
-
$44,000
0.0% of portfolio
-
Q1 2025
Added 20.78%
$0
$147,000
0.0% of portfolio
4,448
Q1 2025
Added 2.68%